Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Clinical Research
You have accessRestricted Access

A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD

Robert Toto, Jeffrey Petersen, Jeffrey S. Berns, Eldrin Foster Lewis, Qui Tran and Matthew R. Weir
JASN February 2021, 32 (2) 469-478; DOI: https://doi.org/10.1681/ASN.2020050556
Robert Toto
1University of Texas Southwestern Medical Center, Dallas, Texas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert Toto
Jeffrey Petersen
2Amgen Inc., Thousand Oaks, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeffrey S. Berns
3Perelman School of Medicine at the University of Pennsylvania and Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eldrin Foster Lewis
4Stanford University Medical School, Stanford, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qui Tran
2Amgen Inc., Thousand Oaks, California
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Qui Tran
Matthew R. Weir
5Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Information

vol. 32 no. 2 469-478
DOI 
https://doi.org/10.1681/ASN.2020050556
PubMed 
33288629

Published By 
American Society of Nephrology
Print ISSN 
1046-6673
Online ISSN 
1533-3450
History 
  • Received for publication May 1, 2020
  • Accepted for publication September 26, 2020
  • Published online January 29, 2021.

Article Versions

  • Earlier version (December 7, 2020 - 08:43).
  • Earlier version (December 10, 2020 - 10:42).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2021 by the American Society of Nephrology

Author Information

  1. Robert Toto1,
  2. Jeffrey Petersen2,
  3. Jeffrey S. Berns3,
  4. Eldrin Foster Lewis4,
  5. Qui Tran2 and
  6. Matthew R. Weir5
  1. 1University of Texas Southwestern Medical Center, Dallas, Texas
  2. 2Amgen Inc., Thousand Oaks, California
  3. 3Perelman School of Medicine at the University of Pennsylvania and Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
  4. 4Stanford University Medical School, Stanford, California
  5. 5Division of Nephrology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
  1. Correspondence:
    Dr. Robert Toto, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas Texas 75230. Email: Robert.toto{at}utsouthwestern.edu

Funding

  • Amgen

  • National Institutes of Health

    R01DK066013; R01HL147422; R01132732; U01DK106102; U01116095

Statistics from Altmetric.com

Article usage

Article usage: December 2020 to April 2022

AbstractFullPdf
Dec 20202483870321
Jan 20211938156146
Feb 2021132813390
Mar 20218408455
Apr 20215325138
May 20213252526
Jun 20211662221
Jul 20211941726
Aug 20211612219
Sep 20211291616
Oct 20211542519
Nov 20212224530
Dec 20211292310
Jan 2022901517
Feb 2022209223
Mar 20221217624
Apr 20221118425
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 32 (2)
Journal of the American Society of Nephrology
Vol. 32, Issue 2
February 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD
Robert Toto, Jeffrey Petersen, Jeffrey S. Berns, Eldrin Foster Lewis, Qui Tran, Matthew R. Weir
JASN Feb 2021, 32 (2) 469-478; DOI: 10.1681/ASN.2020050556

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD
Robert Toto, Jeffrey Petersen, Jeffrey S. Berns, Eldrin Foster Lewis, Qui Tran, Matthew R. Weir
JASN Feb 2021, 32 (2) 469-478; DOI: 10.1681/ASN.2020050556
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Disclosures
    • Funding
    • Acknowledgments
    • Supplemental Material
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and their Combination in Patients with Chronic Kidney Disease: A Randomized Cross-Over Clinical Trial
  • Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis
  • Molecular Characterization of Membranous Nephropathy
Show more Clinical Research

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • PubMed
  • Google Scholar

Keywords

  • chronic kidney disease
  • darbepoetin
  • dosing strategy
  • blood transfusion

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire